What is MASS's market cap?

$457.56M, based on the Nov 4 close of $11.07.

Does 908 Devices pay a dividend?

No regular cash dividend has been paid in the last year.

How much of MASS is sold short?

2.7M shares, 8.7% of float, as of Oct 15, 2026.

What sector is MASS in?

Healthcare, in the Lab Analytical Instruments industry.

NASDAQ · MASSHealthcareLab Analytical Instruments

908 Devices Inc. Common Stock (MASS)

$11.07+3.75%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$11.07▲ 42.84% in range

Nov 4, 2025Low $5.09 · High $12.87Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

908 Devices closed at $11.07 on Nov 4, up 3.75%, 14.0% below its 52-week closing high. Volume of 313.1K shares was 0.87× its 20-day average (close to normal).

Split-adjusted performance: -10.2% over one month, +37.3% over six months, +39.6% over one year.

In the quarter ended Jun 30, 2026, revenue was $16.07M, up 23.3% from a year earlier, with a net margin of -74.0%.

Short interest was 2.7M shares at the Oct 15 settlement (8.7% of float, 7.1 days to cover).

Market cap$457.6M41.3M shares

Revenue · quarter$16.1M+23.3% YoY

Diluted EPS$-0.32—

P/E · TTM—P/S 7.5×

Net margin-74.0%Gross 51.9%

Dividend yieldNone

52-week range5.09 – 12.87−14.0% from high

Volume313.1K0.87× 20-day avg

Volatility · 60d59.7%Annualised

Short % of float8.7%7.1 days to cover

Net cash$101.5MCash $101.5M

Next earnings—Not scheduled

Split-adjusted performance

1W −14.0%1M −10.2%3M +33.4%6M +37.3%YTD +110.9%1Y +39.6%3Y +110.9%5Y −65.4%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Lab Analytical Instruments

Percentile among 22 companies (100 = best)

6-month momentum55

Revenue growth84

Net margin38

Value (low P/E)—

Size43

Industry medians: 6-month return +33.8%, revenue growth +4.9%, net margin −19.0%, P/E 38.3×.

Short interest

Details →

Shares short2.7M−0.7% vs prior

Days to cover7.1Settled Oct 15

% of float8.7%

Short vol. 10d64.5%of daily volume

Closest peers by size in Lab Analytical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
MASS908 Devices	$11.07	+3.75%	+37.3%	+23.3%	−74.0%	—	$457.6M
NAUTNautilus Biotechnolgy	$2.29	−2.55%	−22.1%	—	−6682.1%	—	$291.7M	Compare
CTKBCytek Biosciences	$5.88	−1.34%	+19.0%	+5.6%	−25.3%	—	$764.3M	Compare
PACBPacific Biosciences of California	$2.55	+4.51%	+49.1%	−1.9%	−114.7%	—	$792.6M	Compare
QTRXQuanterix	$3.04	+3.40%	−7.6%	+34.4%	−148.7%	—	$143.8M	Compare
ALMRAlamar Biosciences	$27.39	−9.36%	—	—	−44.9%	—	$1.90B	Compare
SEERSeer	$1.70	−1.73%	−10.1%	−23.4%	−544.8%	—	$94.1M	Compare
HBIOHarvard Bioscience	$8.61	−0.69%	+18.9%	+11.1%	−12.8%	—	$39.2M	Compare
PRPOPrecipio	$19.57	+5.10%	−34.7%	+24.7%	−3.1%	—	$35.0M	Compare

News about 908 Devices

All news →

No recent articles focused on 908 Devices. 1 articles mention it in passing.

Quick answers

What does 908 Devices do?: 908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments.
What is MASS's market cap?: $457.56M, based on the Nov 4 close of $11.07.
Does 908 Devices pay a dividend?: No regular cash dividend has been paid in the last year.
How much of MASS is sold short?: 2.7M shares, 8.7% of float, as of Oct 15, 2026.
What sector is MASS in?: Healthcare, in the Lab Analytical Instruments industry.

About 908 Devices

908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.

HQ: Burlington, MA172 employeesListed Dec 18, 2020908devices.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology